Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Monocytic, Acute × Etoposide × 90 days × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 16 Lymphoma, Large B-Cell, Diffuse 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Medulloblastoma 7 Lung Neoplasms 7 Burkitt Lymphoma 7 Leukemia, Myeloid, Acute 6 Recurrence 5 Brain Neoplasms 5 Sarcoma, Ewing 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Lymphoma 4 Hodgkin Disease 4 Ependymoma 4 Carcinoma, Non-Small-Cell Lung 4 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Glioblastoma 3 Wilms Tumor 2 Teratoma 2 Sarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroendocrine Tumors 2 Neoplasms, Germ Cell and Embryonal 2 Lymphoma, Mantle-Cell 2 Leukemia 2 Glioma 2

Interventions

Injections 2 Gemtuzumab 2 Decitabine 2 ruxolitinib 1 fludarabine 1 fedratinib 1 Whole-Body Irradiation 1 Thiotepa 1 Tacrolimus 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Methotrexate 1 Daunorubicin 1 Cytarabine 1 Cyclosporins 1 Cyclosporine 1 Cyclophosphamide 1 Busulfan 1 Biopsy 1 Azacitidine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡